Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-057409
Filing Date
2011-11-21
Accepted
2011-11-21 17:22:36
Documents
1
Period of Report
2011-11-18

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c25094_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c25094_4x0.xml 4 2929
  Complete submission text file 0001209191-11-057409.txt   4380
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27436 | Film No.: 111219833